Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (BEIGF) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for BeOne Medicines (BEIGF) over the last 10 years, with Q3 2025 value amounting to 0.71.

  • BeOne Medicines' Asset Utilization Ratio rose 2422.44% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 2422.44%. This contributed to the annual value of 0.65 for FY2024, which is 4915.36% up from last year.
  • Latest data reveals that BeOne Medicines reported Asset Utilization Ratio of 0.71 as of Q3 2025, which was up 2422.44% from 0.75 recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Asset Utilization Ratio ranged from a high of 0.75 in Q2 2025 and a low of 0.11 during Q1 2022
  • Its 5-year average for Asset Utilization Ratio is 0.38, with a median of 0.31 in 2023.
  • As far as peak fluctuations go, BeOne Medicines' Asset Utilization Ratio skyrocketed by 25030.41% in 2021, and later plummeted by 2986.77% in 2022.
  • Over the past 5 years, BeOne Medicines' Asset Utilization Ratio (Quarter) stood at 0.17 in 2021, then soared by 36.29% to 0.23 in 2022, then surged by 87.09% to 0.43 in 2023, then skyrocketed by 49.41% to 0.65 in 2024, then grew by 10.09% to 0.71 in 2025.
  • Its Asset Utilization Ratio was 0.71 in Q3 2025, compared to 0.75 in Q2 2025 and 0.71 in Q1 2025.